IN2014DN07797A - - Google Patents

Info

Publication number
IN2014DN07797A
IN2014DN07797A IN7797DEN2014A IN2014DN07797A IN 2014DN07797 A IN2014DN07797 A IN 2014DN07797A IN 7797DEN2014 A IN7797DEN2014 A IN 7797DEN2014A IN 2014DN07797 A IN2014DN07797 A IN 2014DN07797A
Authority
IN
India
Prior art keywords
disintegrating
components
tablet
wet granulation
component
Prior art date
Application number
Other languages
English (en)
Inventor
Takahiro Hiramura
Kiyoshi Ikura
Sae Ishikawa
Tomohito Okabayashi
Naohiro Hashikawa
Tetsuro Morita
Kimiko Ikeda
Haruka WAKAYAMA
Original Assignee
Daicel Corp
Nichirin Chemical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49260166&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014DN07797(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Daicel Corp, Nichirin Chemical Ind filed Critical Daicel Corp
Publication of IN2014DN07797A publication Critical patent/IN2014DN07797A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
IN7797DEN2014 2012-03-29 2013-03-27 IN2014DN07797A (enrdf_load_stackoverflow)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2012075832 2012-03-29
JP2012206895 2012-09-20
JP2012206896 2012-09-20
JP2012275942 2012-12-18
PCT/JP2013/059083 WO2013146917A1 (ja) 2012-03-29 2013-03-27 酸型カルボキシメチルセルロースを含む崩壊性粒子組成物の製造方法、並びに、該組成物及び該組成物を含む口腔内崩壊錠剤

Publications (1)

Publication Number Publication Date
IN2014DN07797A true IN2014DN07797A (enrdf_load_stackoverflow) 2015-05-15

Family

ID=49260166

Family Applications (1)

Application Number Title Priority Date Filing Date
IN7797DEN2014 IN2014DN07797A (enrdf_load_stackoverflow) 2012-03-29 2013-03-27

Country Status (8)

Country Link
US (2) US20150174075A2 (enrdf_load_stackoverflow)
EP (1) EP2832350B1 (enrdf_load_stackoverflow)
JP (1) JP5996633B2 (enrdf_load_stackoverflow)
KR (1) KR101707938B1 (enrdf_load_stackoverflow)
CN (1) CN104080443B (enrdf_load_stackoverflow)
IN (1) IN2014DN07797A (enrdf_load_stackoverflow)
TW (1) TWI610691B (enrdf_load_stackoverflow)
WO (1) WO2013146917A1 (enrdf_load_stackoverflow)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101707938B1 (ko) 2012-03-29 2017-02-17 주식회사 다이셀 산형(酸型) 카르복시 메틸 셀룰로오스를 포함하는 붕해성 입자 조성물의 제조 방법, 및 상기 조성물과 상기 조성물을 포함하는 구강내 붕해 정제
WO2014046035A1 (ja) 2012-09-20 2014-03-27 株式会社ダイセル 酸型カルボキシメチルセルロース及び結晶セルロースを含む崩壊性粒子組成物及び該組成物を含む口腔内崩壊錠剤
US20160136097A1 (en) * 2013-07-06 2016-05-19 Daicel Corporation Ultrafast-disintegrating tablet and method for manufacturing same
US20160213619A1 (en) * 2013-09-27 2016-07-28 Daicel Corporation Intraorally disintegrable tablet comprising disintegrable granular composition
US9974738B2 (en) * 2013-09-27 2018-05-22 Daicel Corporation Disintegrating particle composition produced by two-stage wet granulation process, and intraorally disintegrating tablet containing same composition
JP2017036214A (ja) * 2013-12-10 2017-02-16 株式会社ダイセル 炭酸塩を含む口腔内崩壊錠剤用組成物及び口腔内崩壊錠剤
CN106255512B (zh) * 2014-04-21 2021-01-01 株式会社大赛璐 含有微小纤维状纤维素的崩解性颗粒组合物
JP2017226600A (ja) * 2014-10-16 2017-12-28 株式会社ダイセル 超速崩壊錠剤
JP6704351B2 (ja) 2014-11-24 2020-06-03 株式会社ダイセル 粉砕乳糖又は造粒乳糖を含む崩壊性粒子組成物
WO2016098459A1 (ja) * 2014-12-17 2016-06-23 株式会社ダイセル 遅延崩壊性粒子組成物
CN106999437A (zh) * 2014-12-25 2017-08-01 株式会社大赛璐 超速崩解片剂及其制备方法
JP5897196B1 (ja) * 2015-10-05 2016-03-30 大同化成工業株式会社 糖又は糖アルコール、膨潤型結合剤、崩壊剤及び高吸収性賦形剤を含む複合化造粒物及びその製造方法
TWI767923B (zh) 2016-07-27 2022-06-21 日商澤井製藥股份有限公司 口腔內崩解錠添加用組成物及其製造方法以及口腔內崩解錠
TWI650142B (zh) 2016-09-06 2019-02-11 日商澤井製藥股份有限公司 口腔内崩解錠添加用組成物
KR20210038603A (ko) * 2018-07-25 2021-04-07 주식회사 다이셀 미소섬유상 셀룰로오스를 포함하고, 부형제는 포함하지 않는 붕해성 입자 조성물
JP7360460B2 (ja) * 2019-06-07 2023-10-12 あゆみ製薬株式会社 口腔内崩壊錠及びその製造方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2851453A (en) * 1954-08-09 1958-09-09 Smith Kline French Lab Cellulose derivative product, compositions comprising the same and their preparation
JPH10182436A (ja) 1996-10-31 1998-07-07 Takeda Chem Ind Ltd 固形医薬製剤
JP2000273039A (ja) 1999-01-20 2000-10-03 Taisho Pharmaceut Co Ltd 口腔内崩壊性組成物
US7510728B2 (en) * 2000-10-06 2009-03-31 Takeda Pharmaceutical Company Limited Solid preparations
JP4284017B2 (ja) * 2000-10-06 2009-06-24 武田薬品工業株式会社 固形製剤
JP4551627B2 (ja) 2003-02-28 2010-09-29 東和薬品株式会社 口腔内崩壊錠剤の製造方法
WO2005013964A1 (ja) 2003-08-08 2005-02-17 Ajinomoto Co., Inc. ナテグリニド含有製剤
KR101465803B1 (ko) * 2005-08-10 2014-11-26 시오노기세이야쿠가부시키가이샤 구강내 붕괴 정제
JP5123517B2 (ja) 2005-11-14 2013-01-23 帝人ファーマ株式会社 アンブロキソール口腔内速崩性錠剤
WO2008061226A2 (en) * 2006-11-17 2008-05-22 Supernus Pharmaceuticals Inc. Sustained-release formulations of topiramate
JP5766899B2 (ja) * 2007-04-11 2015-08-19 ニプロ株式会社 口腔内崩壊剤及びその製造方法
JP2008285434A (ja) 2007-05-16 2008-11-27 Taisho Pharm Ind Ltd 口腔内速崩壊錠
ES2639130T3 (es) 2007-06-06 2017-10-25 Basf Se Formulación farmacéutica para la fabricación de comprimidos de rápida desintegración
JP4989733B2 (ja) * 2008-02-13 2012-08-01 大日本住友製薬株式会社 口腔内崩壊錠
KR101753411B1 (ko) * 2008-11-25 2017-07-03 미쓰비시 타나베 파마 코퍼레이션 구강 내 속붕괴성정 및 그의 제조 방법
WO2011019043A1 (ja) 2009-08-11 2011-02-17 大日本住友製薬株式会社 ２種以上の粒子を含有する口腔内速崩壊錠
WO2011019045A1 (ja) * 2009-08-11 2011-02-17 富士化学工業株式会社 崩壊性粒子組成物及び口腔内速崩壊錠
US20110150989A1 (en) 2009-12-22 2011-06-23 Mallinkckrodt Inc. Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans
US9198861B2 (en) * 2009-12-22 2015-12-01 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
JP6073543B2 (ja) 2010-07-08 2017-02-01 沢井製薬株式会社 ロラタジン含有口腔内崩壊錠の製造方法
JP5630902B2 (ja) * 2010-08-26 2014-11-26 沢井製薬株式会社 ゾルピデム酒石酸塩含有口腔内崩壊錠の製造方法
JP6245677B2 (ja) 2012-01-20 2017-12-13 ニプロ株式会社 口腔内崩壊錠
KR101707938B1 (ko) 2012-03-29 2017-02-17 주식회사 다이셀 산형(酸型) 카르복시 메틸 셀룰로오스를 포함하는 붕해성 입자 조성물의 제조 방법, 및 상기 조성물과 상기 조성물을 포함하는 구강내 붕해 정제
WO2014046035A1 (ja) 2012-09-20 2014-03-27 株式会社ダイセル 酸型カルボキシメチルセルロース及び結晶セルロースを含む崩壊性粒子組成物及び該組成物を含む口腔内崩壊錠剤
US9974738B2 (en) * 2013-09-27 2018-05-22 Daicel Corporation Disintegrating particle composition produced by two-stage wet granulation process, and intraorally disintegrating tablet containing same composition
JP6704351B2 (ja) * 2014-11-24 2020-06-03 株式会社ダイセル 粉砕乳糖又は造粒乳糖を含む崩壊性粒子組成物
TWI690333B (zh) * 2015-06-29 2020-04-11 日商大賽璐股份有限公司 易服用性固態製劑（有核錠）之製造方法及易服用性固態製劑

Also Published As

Publication number Publication date
US20150045452A1 (en) 2015-02-12
CN104080443A (zh) 2014-10-01
TWI610691B (zh) 2018-01-11
CN104080443B (zh) 2017-12-12
EP2832350A4 (en) 2015-11-18
WO2013146917A1 (ja) 2013-10-03
JPWO2013146917A1 (ja) 2015-12-14
US20150174075A2 (en) 2015-06-25
US20200038332A1 (en) 2020-02-06
EP2832350B1 (en) 2019-07-17
KR20140144249A (ko) 2014-12-18
US12059501B2 (en) 2024-08-13
EP2832350A1 (en) 2015-02-04
KR101707938B1 (ko) 2017-02-17
JP5996633B2 (ja) 2016-09-21
TW201400145A (zh) 2014-01-01

Similar Documents

Publication Publication Date Title
IN2014DN07797A (enrdf_load_stackoverflow)
WO2014014835A3 (en) Criystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid
WO2014101986A8 (en) Dry granulation process for producing tablet compositions of metformin and compositions thereof
WO2013152051A3 (en) Improved production of fatty acid derivatives
HK1206779A1 (en) Modified polynucleotides for the production of nuclear proteins
IN2013MN02445A (enrdf_load_stackoverflow)
BR112012011995A2 (pt) uso de prostaglandinas f2alfa e análogos para a cicatrização de lesões da córnea e conjuntiva.
IN2015DN02907A (enrdf_load_stackoverflow)
NZ628964A (en) Supercritical hydrolysis of biomass
BR112013026297A2 (pt) ésteres de resina de colofônia para não tecidos
WO2012101429A3 (en) A pellet
NZ607149A (en) Galacto-oligosaccharide-containing composition and a method of producing it
BR112013022638A2 (pt) processo para a produção de açúcares hemicelulósicos fermentáveis e biomassa com baixo teor de cinzas a partir de biomassa celulósica; processo para a produção de açúcares hemicelulósicos fermentáveis e potência a partir de biomassa celulósica; e processo para a produção de açúcares hemicelulósicos fermentáveis e péletes de biomassa a partir de biomassa celulósica
NZ593787A (en) Lyophilised dabigatran
WO2014199322A3 (en) Wear resistant compositions with low particulate contamination and method of making those compositions
EA201201119A1 (ru) Панель гипсокартона и способ изготовления панели гипсокартона
CA2876532C (en) Process for producing cell culture media
PH12015500794A1 (en) Monohydrate crystal of fimasartan potassium salt, method for preparing same, and pharmacological composition comprising same
WO2014182684A3 (en) Methods and compositions related to large scale production of proteins
TR201009167A2 (tr) Sefalosporin içeren farmasötik granüller.
MX2015013801A (es) Proceso de radioetiquetado.
TR201103625A1 (tr) Sefuroksim içeren tablet formülasyonu üretim prosesi.
WO2012159981A3 (en) PROCESS FOR THE PREPARATION OF α-SUBSTITUTED KETONES AND THEIR APPLICATION IN SYNTHESIS OF PHARMACEUTICALLY ACTIVE COMPOUNDS
MX346497B (es) Compuestos para la diferenciacion de celulas madre mejorada en hepatocitos.
HK1210436A1 (en) Novel cell compositions and methods